X-ray generator developer Creos International of Fife, Scotland, has been encountering financial problems of late. The company last month requested that its shares be suspended from trading on the Alternative Investment Market of the U.K. while it
X-ray generator developer Creos International of Fife, Scotland, has been encountering financial problems of late. The company last month requested that its shares be suspended from trading on the Alternative Investment Market of the U.K. while it considers its financial position. The company has closed its subsidiary, Creos Limited, and is seeking the appointment of a provisional liquidator.
The companys compact x-ray generator technology will live on, however. In December, Creos Limiteds U.S. subsidiary, Creos Inc., sold its business and assets to Colorado businessman Peter Cooper, who founded a new, private company, Creos Technologies of Englewood, CO. Creos Technologies employs 33 people and manufactures the high-powered, high-frequency x-ray generators initially developed by Creos International (SCAN 7/13/94). Creos International holds a residual interest in the new company.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
2 Commerce Drive
Cranbury, NJ 08512